concept

SUBSTANTIA NIGRA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SUBSTANTIA NIGRA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

766Connections

1Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

Summary

SUBSTANTIA NIGRA is a concept in neurodegeneration research. Key relationships include: co discussed, associated with, regulates. Associated with PARKINSON, PARKINSON'S, PARKINSON'S DISEASE. Connected to 79 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	SUBSTANTIA NIGRA
Key Genes/Proteins	AIF1, AKT, ALPHA-SYNUCLEIN, AMPK, AMYLOID, APP
Related Diseases	ALZHEIMER'S DISEASE, APOPTOSIS, ATP
Related Pathways	AMPK SIGNALING

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Substantia Nigra Neurons

cell · 821 words

→

Pathway Diagram

graph TD
    SUBSTANTIA_NIGRA["SUBSTANTIA NIGRA"]
    SUBSTANTIA_NIGRA -->|"interacts"| Dopamine["Dopamine"]
    dopaminergic_neurons["dopaminergic neurons"] -->|"expressed in"| SUBSTANTIA_NIGRA
    Dopamine -->|"interacts"| SUBSTANTIA_NIGRA
    lipopolysaccharide["lipopolysaccharide"] -->|"activates"| SUBSTANTIA_NIGRA
    GCASE["GCASE"] -->|"expressed in"| SUBSTANTIA_NIGRA
    NEURON["NEURON"] -->|"expressed in"| SUBSTANTIA_NIGRA
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"expressed in"| SUBSTANTIA_NIGRA
    PARKINSON["PARKINSON"] -->|"expressed in"| SUBSTANTIA_NIGRA
    PLIN2["PLIN2"] -->|"expressed in"| SUBSTANTIA_NIGRA
    NEURODEGENERATION["NEURODEGENERATION"] -->|"expressed in"| SUBSTANTIA_NIGRA
    ALPHA_SYNUCLEIN["ALPHA-SYNUCLEIN"] -->|"expressed in"| SUBSTANTIA_NIGRA

Outgoing (162)

Target	Relation	Type	Str
dopamine-producing neurons	expressed_in	cell_type	0.90
Dopamine	regulates	entity	0.70
Dopamine	interacts_with	entity	0.70
DOPAMINERGIC NEURONS	stabilizes	cell_type	0.70
L-DOPA	inhibits	drug	0.70
STROKE	regulates	disease	0.70
Dopamine	activates	entity	0.70
BASAL GANGLIA	causes	brain_region	0.65
SYNAPTIC PLASTICITY	regulates	phenotype	0.65
NEURODEGENERATION	activates	disease	0.65
GLIOSIS	interacts_with	phenotype	0.65
OXIDATIVE STRESS	activates	phenotype	0.65
TH	causes	gene	0.65
GLIOSIS	inhibits	phenotype	0.65
PARKINSON'S DISEASE	treats	disease	0.65
UBIQUITIN	transports	protein	0.65
TH	regulates	gene	0.60
Parkinson	loss_affects	entity	0.60
DOPAMINERGIC	interacts_with	concept	0.50
SYNUCLEIN	interacts_with	concept	0.50
DOPAMINERGIC NEURONS	interacts_with	concept	0.50
RAPAMYCIN	interacts_with	concept	0.50
CENTRAL NERVOUS SYSTEM	interacts_with	concept	0.50
DOPAMINERGIC NEURONS	associated_with	concept	0.50
PARKINSON'S	interacts_with	concept	0.50
DOPAMINERGIC	inhibits	concept	0.50
DOPAMINE	inhibits	concept	0.50
DOPAMINERGIC NEURONS	inhibits	concept	0.50
DOPAMINE	associated_with	concept	0.50
DOPAMINERGIC	activates	concept	0.50
STRIATUM	activates	concept	0.50
DOPAMINERGIC NEURONS	activates	concept	0.50
PI3K/AKT/mTOR	activates	pathway	0.50
Proteins	activates	protein	0.50
MTOR SIGNALING	activates	concept	0.50
Proteins	associated_with	protein	0.50
PREFRONTAL CORTEX	activates	concept	0.50
VENTRAL TEGMENTAL AREA	activates	brain_region	0.50
TNF	co_discussed	entity	0.50
TREM2	co_discussed	entity	0.50
THALAMUS	co_discussed	entity	0.50
PARKINSON'S	associated_with	concept	0.50
SYNUCLEIN	associated_with	concept	0.50
α-SYNUCLEIN	associated_with	concept	0.50
STRIATUM	associated_with	concept	0.50
AADC	activates	concept	0.50
PARKINSON'S	expressed_in	concept	0.50
ST3GAL2	expressed_in	concept	0.50
GENE EXPRESSION	expressed_in	concept	0.50
ULK1	associated_with	gene	0.50

Incoming (604)

Source	Relation	Type	Str
PARKINSON'S DISEASE	associated_with	disease	1.00
MICROGLIA	associated_with	cell_type	1.00
DOPAMINERGIC NEURONS	causes	cell_type	0.95
DOPAMINERGIC NEURONS	expressed_in	entity	0.95
Parkinson's Disease	associated_with	disease	0.95
DOPAMINERGIC NEURONS	associated_with	cell_type	0.95
IL-6	expressed_in	protein	0.90
MN	associated_with	compound	0.90
Parkinson'S Disease	associated_with	disease	0.90
FE	associated_with	compound	0.90
m6A deficiency	associated_with	process	0.90
Tyrosine Hydroxylase	expressed_in	enzyme	0.90
LEPTIN	expressed_in	protein	0.90
METTL3	expressed_in	gene	0.90
Parkinson's disease	affects	disease	0.90
alpha-synuclein	causes	protein	0.90
neurodegeneration	affects	disease	0.90
PARK2 Deficiency	causes	phenotype	0.88
Reduced Gangliosides	biomarker_for	biomarker	0.85
SNCA	causes	protein	0.85
MCH	expressed_in	protein	0.85
MCH Neurons	expressed_in	cell_type	0.85
PARKIN	associated_with	gene	0.82
TH	expressed_in	gene	0.80
neuroinflammation	affects	disease	0.80
REV-ERBα	expressed_in	protein	0.80
TP53	expressed_in	gene	0.75
TNF	associated_with	gene	0.74
NF-KB	associated_with	protein	0.74
BDNF	protects_against	gene	0.70
ASC	expressed_in	gene	0.70
dopaminergic neurons	expressed_in	cell_type	0.70
lipopolysaccharide	activates	drug	0.70
Parkinson's disease	associated_with	disease	0.70
Dopamine	interacts_with	entity	0.70
unfolded protein response	active_in	pathway	0.70
TFEB	protects_against	gene	0.70
TFEB	regulates	gene	0.70
AUTOPHAGY	causes	phenotype	0.70
TREM2	expressed_in	gene	0.70
TREM2	associated_with	gene	0.66
IL-1B	associated_with	gene	0.66
PARKINSON'S DISEASE	causes	disease	0.66
MTOR	associated_with	gene	0.66
AUTOPHAGY	inhibits	process	0.66
ASTROCYTES	associated_with	cell_type	0.66
NICOTINAMIDE	protects_against	drug	0.65
NEURONS	sensitizes_to	cell_type	0.65
NICOTINAMIDE	inhibits	drug	0.65
ALPHA-SYNUCLEIN	contributes_to	gene	0.65

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
AAV-Mediated RGS6 Overexpression in Substantia Nigra Parvoce	0.424	neurodegeneration	Does RGS6 upregulation or D2 autorecepto

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning SUBSTANTIA NIGRA in their description or question text

No additional research found